The management of neuropathic pain in cancer: Clinical guidelines for the use of adjuvant analgesics

Indian Journal of Cancer

Volumn 37, Issue 1, 2000, Pages 4-9

  George, Reena M ^a   Ahmedzai, Sam H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT;

CASE REPORT; HUMAN; INTRACTABLE PAIN; MALE; NEOPLASM; NEURALGIA; PRACTICE GUIDELINE; REVIEW;

ANALGESICS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; HUMANS; MALE; NEOPLASMS; NEURALGIA; PAIN, INTRACTABLE; PRACTICE GUIDELINES;

EID: 0034158464     PISSN: 0019509X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Martin L.A., Hagen N.A. :Neuropathic pain in cancer patients: mechanisms, syndromes, and clinical controversies. J Pain Symptom Manage 1997:14;99-117.
2. Grond S., Zech D., Diefenbach C., Radbrucb L. and Lehmann K.A.: Assessment of cancer pain : a prospective evaluation in 2266 cancer patients referred to a pain service. Pain 1996:64;107-14.
3. Glynn C.: An approach to the management of the patient with deafferentation pain. Palliative medicine 1989:3;13-21.
4. Backonja M.M., Galer B.G.: Pain assessment and evaluation of patients who have neuropathic pain. Neurologic Clinics of North America 1998:16;775-788.
5. Twycross R.: Symptom Management in Advanced Cancer, 2nd Ed. Radcliffe Medical Press, Oxford, 1997.
6. nd Ed, Geneva WHO, 1996.
7. Janjan N.A.: Pain Management In Perez CA, Brady LW ed. Principles and Practice of Radiation Oncology 3rd Ed. Lippincott Raven, Philadelphia 1998:2227-2242.
8. Rohakiner A.Z.S., Slevin M.L., Tate T.: Palliative Medicine and Symptom Control In Kumar P and Clark M ed, Clinical Medicine 3rd Ed WB Saunders Company London 1994:376-378.
9. Expert Working Group of the European Association of Palliative Care: Morphine in cancer pain: modes of administration Br. Med J. 1996:312;823-826.
10. Allen R.R.: Neuropathic pain in the cancer patient. Neuroapthic pain in the cancer patient. Neurologic Clinics of North America 1998:16;869-887.
11. rd Ed Oxford University Press, Oxford, 1998-361-390.
12. Twycross R.: Opioids In Wall PD and Mezlack R Eds. Textbook of Pain 4th ed Churchill Livingstone London 1999:1187-1214.
13. Hanks G.W., Forbes K. : Opioid responsiveness Acta Anaesthesiol Scand 1997:41;154-158.
14. Grond S., Radbruch L., Mueser T., Sabotowski R., Loick G., Lehmann K.A. : Assessment and treatment of neuropathic pain following WHO guidelines Pain 1999:79;15-20.
15. Portenoy R.K. and Mccaffery M.: Adjuvant analgesics in : McCaffery M and Pasero C. Eds Pain Clinical Manual2nd ed Mobsy, Missouri 1999:300-361.
16. McQyay H.J. and Moore R.A. : Antidepressants in neuropathic pain in An evidence based resource for pain relief Oxford University press, Oxford 1998:231-241.
17. McQyay H.J., Carroll D. and Glynn C.J.: Dose-response for analgesic effect of amitryptiline in chronic pain. Anaesthesia 1993:48;281-285.
18. McQuay H. and Moore R.A. : Anticonvulsant drugs In An Evidence Based Resource for Pain Relief, Oxford University Press, Oxford 1998:221-230.
19. Twycross R., Wilcock A. and Thorp S: Palliative Care Formulary, Radcliffe Medical Press, Oxford 1998.
20. Twycross R. : Introducing Palliative care, Radcliffe Medical Press, Oxford 1997.
21. Galer B.G. : Painful Polyneuropathy, Neurologic Clinics of North America 1998:16;791-811.
22. Rajagopal M.R.: Cancer pain emergencies : J Pain Symptom Management 1998:15;264-5.
23. Vecht Ch J., Haaxma-Reiche H. and van Putten W.L.J.: Initial bolus of conventional versus high dose dexamethasone in metastatic spinal cord compression Neurology 1989:39;1255-1257.
24. Chong V.T.: Intravenous phenytoin in the management of crescendo pelvic caner related pain, J Pain and Symptom Manage. 1997:13,238-240.
25. Ferrante K.M., Paggioli J., Cherukiri S. and Arthur G.R.: The analgesic response to intravenous lidocaine in the treatment of neuropathic pain, Anaesthesia Analgesia 1996:82;91-97.
26. Dejgard A., Peterson P and Kastrup J.: Mexiletene for the treatment of painful diabetic neuropathy. Lancet 1998:1;9-11.
27. Dunlop R., Davis R. J., Hockley J. and Turner P.: Analgesic effects of oral flecainide Lancet 1988:1;420-1.
28. Rowbotham M., Harden N., Stacey B., Bernstein P., and Magnus-Miller L. : Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial JAMA 1998:280;1837-42.
29. Backonja M., Beydoun A., Edwards K.R. Schwartz S.L., Fonseca V., Hes M., LaMoreaux L. and Garofalo E. : Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998:280;1831-1835.
30. Waston C.P.N. Evans R. J.: The post mastectomy pain syndrome and topical capsaicin: A randomised trial Pain 1992:5;375-379.
31. Rowbotham M.C., Davies P.S. and Fields H.L. : Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurology 1997:37;246-253.
32. Grady K.M., Severn A.M. : Key topics in Chronic pain Bios Scientific Publishers Oxford 1997-994-97.
33. Mercadante S. : Ketamine in cancer pain : an update Palliative Medicine 1996 10:225-30.
34. Pud D., Eisenberg E., Spitzer A., Adler R., Fried G. and Yarnitsky D. : The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: a double blind, randomized, placebo controlled trial. Pain 1998:75,349-54.
35. Portenoy R. K., Lesage P. : Management of cancer pain Lancet 1999:353;1695-1700.